chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. There was no information about patient's concomitant medications and pertinent medical history reported. On an unknown date, the unspecified number of patients were vaccinated with improperly stored (in temperature 34-35 - unit unknown) unspecified doses of PROQUAD (Merck) lot # K023862, expiry date: 25-MAY-2016 or lot# L011079, expiry date: 01-OCT-2016 or lot# L004006, expiry date: 05-AUG-2016 (dose, site and route of administration were not reported). This is one of several reports received from the same reporter. Additional information has been requested.
Per the individual's report:  -Slept for 3 days after the injection due to flu like symptoms  1/11/2020- 3 small blisters on left lower back appeared 1/16/2020- Saw urgent care Dr.- told it was not concerning 1/17/2020- Saw dermatologist- blisters cultured- started on valacyclovir 500mg BID for 7 days and mupirocin ointment BID. 1/24/2020- follow up with dermatologist- 3 more blisters on right side of face- cultured- notified that first culture was positive for herpes virus 1/30/2020- notified that second culture was positive for herpes virus. Original course of treatment completed and blisters were healed at this point- no further course of treatment.  Client's blisters never itched, burned, hurt or caused any sort of discomfort per the individual.
On Tuesday the 7th of September, I started having a running nose and couldn't breathe well. I went to the pharmacy to get some Sufafed and it was suggested that I test for COVID-19. I tested positive. I called clinic and they prescribed Paxlovid, and 4 days after I tested negative. During this infection, I was very fatigued and it was hard to stay awake during this time. The 2nd infection started last Wednesday 10/19/2022. I tested positive again. I was traveling with relatives and one of them tested positive. I did not have any symptoms at the time. I just had a stuffy nose and I tested positive again. I called my PCP and they noted they would not prescribe Paxlovid again that close together. I've been treating it with over the counter medicine. I finally tested negative today. This infection did last a bit longer without Paxlovid.
For 5 days after the shot, I was about 70% for a majority of the day. Body aches, low grade fever, cough, extreme tiredness. Every evening between 5-8 pm, I would spike a 102/103 temp, with extreme body aches and chills. By early morning usually around 3 or 4 my fever would break and I would feel about 70% throughout the day. On the 6 day of this, I went to the doctor and they told me I had bronchitis. It has been 3 weeks since my shot and I still have a residual cough and tiredness.
I got large swollen lymph nodes in my right armpit; They hurt alot to have my arms down/I still have that pain on day 3 after the shot; headache; muscle pain; extreme fatigue; laid in bed all day; nausea; arm pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 10Apr2021 14:45 (Lot number: EP7533) at the age of 42 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "IBS" (unspecified if ongoing); "endometriosis" (unspecified if ongoing); "hypothyroid" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Bnt162b2 (lot number=ER8727, administration time=02:30 PM, vaccine location=Left arm, dose number=1), administration date: 20Mar2021, when the patient was 42 years old, for Covid-19 immunisation, reaction(s): "First shot I got a large red circle around the injection sight", "It hurt", "itchy", "It got hard". The following information was reported: LYMPHADENOPATHY (non-serious) with onset 10Apr2021 18:00, outcome "recovering", described as "I got large swollen lymph nodes in my right armpit"; AXILLARY PAIN (non-serious) with onset 10Apr2021 18:00, outcome "recovering", described as "They hurt alot to have my arms down/I still have that pain on day 3 after the shot"; HEADACHE (non-serious) with onset 10Apr2021 18:00, outcome "recovering", described as "headache"; MYALGIA (non-serious) with onset 10Apr2021 18:00, outcome "recovering", described as "muscle pain"; FATIGUE (non-serious) with onset 10Apr2021 18:00, outcome "recovering", described as "extreme fatigue"; BEDRIDDEN (non-serious) with onset 10Apr2021 18:00, outcome "recovering", described as "laid in bed all day"; NAUSEA (non-serious) with onset 10Apr2021 18:00, outcome "recovering", described as "nausea"; PAIN IN EXTREMITY (non-serious) with onset 10Apr2021 18:00, outcome "recovering", described as "arm pain". Therapeutic measures were not taken as a result of lymphadenopathy, axillary pain, headache, myalgia, fatigue, bedridden, nausea, pain in extremity. Additional information: Patient got first shot and got a large red circle around the injection site. It got hard and went away in a week. It also got itchy. After second shot she got large swollen lymph nodes in her right armpit. They hurt a lot to keep her arms down. She still have pain on third day after the shot. She also had a headache, muscle pain, extreme fatigue (laid in bed all day), nausea, arm pain within hours of receiving the shot on Saturday. She had not received any other vaccine in four weeks. She is under concomitant medications in two weeks which include prescribed and OTC. She was not tested positive for COVID prior to vaccination and was not tested positive post vaccination. She had no known allergies.  No follow-up attempts are possible. No further information is expected.
Itchy; There was a bump; Arm was red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (There was a bump) and VACCINATION SITE ERYTHEMA (Arm was red) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concomitant products included APIXABAN (ELIQUIS), ASCORBIC ACID, BETACAROTENE, CUPRIC OXIDE, TOCOPHERYL ACETATE, ZINC OXIDE (PRESERVISION), PARACETAMOL (TYLENOL), POTASSIUM CHLORIDE (KLOR-CON), TRAMADOL, CITALOPRAM, FUROSEMIDE, GABAPENTIN, LISINOPRIL and LORAZEPAM for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (There was a bump) and VACCINATION SITE ERYTHEMA (Arm was red). At the time of the report, VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (There was a bump) and VACCINATION SITE ERYTHEMA (Arm was red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included cream for pain and reported that it helped in itching.   The patient reported that even though she had some side effects it was feeling fantastic and had not consulted any physician.   Most recent FOLLOW-UP information incorporated above includes: On 26-Mar-2021: Follow up document received on 26-Mar-2021 and information related to medical confirmation was added. On 28-Jun-2021: Follow-up document received on 28-Jun-2021 and contains no newinformation.
persiseant hypoglycemia, cardiomyopathy with pulmonary edema, encephalopathy, elevated inflammatory markers, (ddimer, crp, esr)
On the evening of 10/30/00 post vaccination the pt experienced 8 to 9 cm deltoid erythema with some induration, swelling and pain at the injection site. the physician reported the erythema was 2 cm away from injection site. The area appeared scalded. On 11/01/00 the pt was seen by her Dr and Claritin, ice and Benadryl were prescribed without any relief. The pt did recover.
Vomiting (2 times), Spotty rash on chest and back, lethargy. Eye blinking and mouth twitching, right arm jerked, subtle twitching of right leg. Entire episode lasted about three minutes. Fever and all symptoms were gone by next morning.
Pt recevd 3 vax, the 3rd of which was Engerix B and tested negative for anti-hepatitis B surface antigen.
Pt developed severe diarrhea, nausea, decreased appetite within 24 hours of vaccine administration
patient received her first dose last year in June of 2022 by a different provider, but missed her subsequent doses; This spontaneous report was received from Pharmacist and refers to a 45-year-old female patient.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On an unknown date in June 2022, the patient started therapy with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided), but missed her subsequent doses and was seeking to finish the vaccination series (Inappropriate schedule of product administration).
Felt weak & tired, red eyes, emesis, nausea about 5 hours after receiving flu vaccine.
Redness and itching at injection site.  Red raised bump in circle formation about 1.5? to 2? around injection site. A week and a half after 1st dose.
On 12/20 at 9am started having left sided facial numbness, tingling, flushing. Near syncope episode (tachycardia, diaphoretic, blurred vision) around 1130am. Took Benadryl seemed to help. On 12/21- around 7a near syncope episode, tachycardia, diaphoretic, facial flushing, itching.  Took Benadryl-improvement in facial itching, decreased heart rate.
After Pfizer Pediatric Covid 19 vaccine was administered, child waited in office with mother.  Child became lethargic/sleepy about 10-15 minutes after receiving vaccine.
Nausea Chills Fever Body aches Severe Headache Low back pain Symptoms lasted 48 hours Treated the symptoms and stayed in bed
vaccination failure; shingles; This case was reported by a nurse via sales rep and described the occurrence of vaccination failure in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 9th May 2018, the patient received the 1st dose of Shingrix. On 17th August 2018, the patient received the 2nd dose of Shingrix. On 1st May 2019, 357 days after receiving Shingrix and 257 days after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but the could be of 73 or 74 years. The patient had shingles after being vaccinated with Shingrix two doses.
my sprained ankle is so much better; my sprained ankle is so much better; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (my sprained ankle is so much better) and PRE-EXISTING CONDITION IMPROVED (my sprained ankle is so much better) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (my sprained ankle is so much better) and PRE-EXISTING CONDITION IMPROVED (my sprained ankle is so much better). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (my sprained ankle is so much better) and PRE-EXISTING CONDITION IMPROVED (my sprained ankle is so much better) outcome was unknown.            The patient reported that after her second dose of mRNA-1273 her arthritis has gotten much better Concomitant medication was not reported. Treatment information was not provided.
Pt. came in to report to our pharmacy manager that her arm was extremely sore after her shot. Couldn't lift it. She saw her MD on 10/13/15 - he diagnosed shoulder bursitis from receiving injection into the bursa which will require 4 weeks of physical therapy.
Left deltoid area with extending erythema, warmth, pain and induration with decreased range of movement left arm, left cellulitis.
No adverse effects; a 7 month old infant was administered VARIVAX; This spontaneous report was received from a nurse referring to a 7-month-old patient of unknown gender. The patient's concurrent conditions, medical history, concomitant therapies and drug reactions/allergies were not provided.  On 16-AUG-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (lot # R034398, expiration date: 27-NOV-2020), 1 dose, subcutaneously for prophylaxis (Inappropriate age at vaccine administration). No adverse effects were reported.
1 week after vaccination, patient noticed a hive-like reaction, 1/2 inch under injection site. Doctor prescribed antibiotics but could not tell if reaction to vaccine.
Chest pressure/discomfort x7 days, received 1st dose of COVID vacc 10 days ago ( Oct 29). discomfort worse when laying on side. had outside labs done 11/3. PHQ=7, GAD10  Describes pain as "irritating constant pressure that sometimes ... catches my breath".  Most of the time describes as dull constant pressure, squeezing feeling rates 2-3/10  intermittent sharp feeling rates as 6/10.  Treatments tried, repositioning, tums and anticids, aleve, tylenol.  no relief.  No trauma neither remote nor near to thorax nor neck, no previous similar symptoms.  Pain also shoots down RIGHT arm and hand.  Can't feel her 3rd - 5th digits.   Had COVID vax Moderna 1st shot on Oct 29 (a Friday), had mild fever/chills, chest pain over the weekend.  Started to feel better on Sunday.  Then Monday morning the chest pain started and has been unrelenting.  Otherwise, she is able to take a deep breath, no cough, no wheeze, no nausea, vomiting, diarrhea, constipation, heartburn, nor gas.
Patient is an Facility. The Health Department provides vaccines to those who request them. The patient filled out the screening form and reported he had not received any previous Covid vaccine. Patient was given the Janssen vaccine. When inputting into system it was noted this was the third dose. Patient had received his first and second dose of Moderna at a Family Practice. This writer called to confirm vaccines were given and was told consent forms were signed on both occasions. Facility notified of adverse event. The nurse who administered the vaccine stated that the patient filled out the screening form and answered he had not received any previous doses of the Covid vaccine. Patient to be monitored for any adverse side effects.
I woke up out of a sound sleep aprox 12 hours after injection with high fever, chills, body aches, vomiting, extreme headache, dizziness  and almost fainted.  I ran a fever until after 54 hours.  Developed an itchy rash, around the injection site on day 9.
On 10/12, I received my first dose of Moderna. Some of the symptoms I had did not show up for 2 weeks. They were as follows: ringing in my ears, metallic taste in my mouth, inflammation to my right eye, right sided weakness/tingling/numbness, daily migraines.   After my 2nd dose on 11/9/21, the adverse events appeared  2 days later and have yet, as of today (12/2/21), to improve. They have been as follows: high blood pressure to low blood pressure with position changes, constant chest pain, migraines, joint pain, right sided weakness/numbness/tingling, inflammation of my right eye, ringing in my right ear.
patients were administered improperly stored doses; no adverse effect; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's relevant medical history, concurrent conditions and concomitant medications were unknown.  On 28-MAR-2019, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # R024022 and expiration date 22-AUG-2019 for prophylaxis (dose, strength, frequency and route of administration were unknown).    The patient experienced no adverse effects. It was reported that the vaccine was stored at a temperature of -9C to 8C (1C) during a time frame of 1 hour, 44 minutes. The vaccine had not experienced previous temperature excursions. Digital data logger was involved.; Sender's Comments:  US-009507513-1904USA009984: US-009507513-1904USA010119:
Blistering rash on right arm, then approx. 1 week later, blistering, dermatomal rash on left anterior leg with extreme pain, erythema, edema
Right arm was like a ball of fire, a knot with fingers squeezing constantly. Very Very intense pain. Had physical therapy and massages.
Information has been received from a physician concerning a male pt who on 6/23/06 was vaccinated with a dose of MMR II/Varicella vaccine (lot 652328/0956R). Subsequently, on 7/6/06, thirteen days after vaccination, the pt developed a rash. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Very mild headache on day of admin of 2nd dose. Difficulty sleeping. Then awoke with intense body aches at 3am could not go back to sleep. Muscle and joint pain, body aches, and intermittent headache with pressure. Still experiencing.
Autoimmune attack vasculitis resulting in mononeuristis polymutiplex, paralysis and neuropathy; Autoimmune attack vasculitis resulting in mononeuristis polymutiplex, paralysis and neuropathy; Autoimmune attack vasculitis resulting in mononeuristis polymutiplex, paralysis and neuropathy; Autoimmune attack vasculitis resulting in mononeuristis polymutiplex, paralysis and neuropathy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 30Apr2021 (Lot number: ER8733) at the age of 52 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Sulfa drugs" (unspecified if ongoing), notes: Known allergies: Sulfa drugs; "Autoimmune in remission" (unspecified if ongoing), notes: Autoimmune in remission. Concomitant medication(s) included: LEVOTHYROXINE. Past drug history included: Tetracycline, reaction(s): "Known allergies: Tetracycline", notes: Known allergies: Tetracycline. Vaccination history included: Bnt162b2 (Lot number: EW0164, Anatomical location: Left arm, Dose Number: 1), administration date: 09Apr2021, when the patient was 52 years old, for COVID-19 Immunization.  The following information was reported: NEUROPATHY PERIPHERAL (hospitalization, disability, medically significant), PARALYSIS (hospitalization, disability, medically significant), VASCULITIS (hospitalization, disability), MONONEUROPATHY MULTIPLEX (hospitalization, disability) all with onset 13Jun2021, outcome "unknown" and all described as "Autoimmune attack vasculitis resulting in mononeuristis polymutiplex, paralysis and neuropathy". The patient was hospitalized for neuropathy peripheral, paralysis, vasculitis, mononeuropathy multiplex (hospitalization duration: 12 day(s)). The event "autoimmune attack vasculitis resulting in mononeuristis polymutiplex, paralysis and neuropathy", "autoimmune attack vasculitis resulting in mononeuristis polymutiplex, paralysis and neuropathy", "autoimmune attack vasculitis resulting in mononeuristis polymutiplex, paralysis and neuropathy" and "autoimmune attack vasculitis resulting in mononeuristis polymutiplex, paralysis and neuropathy" was evaluated at the physician office visit and emergency room visit. Therapeutic measures were taken included Ivig, Cytoxan, truxima, IV Lasik as a result of neuropathy peripheral, paralysis, vasculitis, mononeuropathy multiplex.  Clinical information: Adverse event reported as Autoimmune attack vasculitis resulting in mononeuritis polymutiplex, paralysis and neuropathy. The patient had not received other vaccine in four weeks. Patient did not had COVID prior to vaccination. Patient was not tested for COVID post vaccination.  Follow-up attempts are completed. No further information is expected.
This non-serious spontaneous case, initially received from a physician via pharmaceutical manufacturer Merck (reference number: 00843915) on 12-Jun-2018, concerning a female patient of an unspecified age. The patient had been allergic to morphine, nickel, formaldehyde and bee stings. On an unspecified date, the patient was administered with INN Flu Vaccine Seasonal (dose, route of administration, anatomical location, batch number, expiry date, manufacturer and trade name: not reported). On an unspecified date, after vaccination, the patient experienced allergies (unspecified). At the time of this report, the outcome of the event was not reported. The reporter considered the causality of the event as related to suspect vaccine.
Became pregnant end of December. Received first dose January 6 and second dose January 27. Had very bad side effects. Felt pregnancy symptoms up until February 10th. Symptoms started to linger off. Had ultrasound that  showed fetus February 10. Cramping started feeling days later. Had ultrasound again February 18 showed fetus had grown. Had another ultrasound February 21 after going to ED for bad cramping and pain. fetus had no heart beat. Miscarried February 26. Contents did not pass completely, had D&C February 27.
Developing tingling in arm after shot from shoulder to wrist, unknown if tingling is permanent suspect nerve damage.